Context Therapeutics
CNTX
CNTX
24 hedge funds and large institutions have $2.55M invested in Context Therapeutics in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
45% less capital invested
Capital invested by funds: $4.59M → $2.55M (-$2.04M)
Holders
24
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$69.9K | |
| 2 | +$62.8K | |
| 3 | +$38K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$9.14K |
| 5 |
AWM
Aspire Wealth Management
Waltham,
Massachusetts
|
+$6.52K |
Top Sellers
| 1 | -$155K | |
| 2 | -$122K | |
| 3 | -$96.5K | |
| 4 |
QC
Quadrature Capital
London,
United Kingdom
|
-$51K |
| 5 |
Jane Street
New York
|
-$34K |